Approved ASO drugs target exon 45 (casimersen), 264,496 exon 51 (eteplirsen), 497,498 and exon 53 (golodirsen and viltolarsen) 80,263 to induce specific exon skipping in the dystrophin gene, thus delaying disease progression
With locations in Scottsdale and Mesa, we offer medically supervised peptide therapy, GLP-1 weight loss programs, hormone optimization, and more for patients throughout the Valley
WeightWatchers builds several safety layers into its program
Whether its drinking tons of water, hair of the dog, or a breakfast of fast food burgers, none of these really work to prevent or reduce a hangover
GHK-Cu Research Overview Recognized for its regenerative properties, GHK-Cu is widely examined for its impact on skin structure and cellular repair